Skip to main content

Advertisement

Table 1 Patient’s characteristics (n = 57)

From: The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects

Variable
Age (ys) 51.0 ± 9.8
Gender, n(%)
 Male 50 (87.7)
 Female 7 (12.3)
BMI (Kg/m2) 25.7 ± 3.6
Level of instruction (ys) 10.8 ± 3.1
History of HIV infection (ys) 11.1 ± 7.5
Risk factors, n(%)
 MSM 22 (38.6)
 Ex-IDU 11 (19.1)
 Heterosexual 24 (42.1)
Therapy, n(%)
 NRTI 53 (93.0)
 NNRTI 20 (35.1)
 IP 20 (35.1)
 INSTIs 20 (35.1)
HCV, n(%) 9 (15.8)
HBV, n(%) 6 (10.5)
Glycaemia (mg/dl) 98.8 ± 48.8
Total cholesterol (mg/dl) 198.2 ± 44.2
HDL cholesterol (mg/dl) 51.8 ± 16.9
LDL cholesterol (mg/dl) 113.4 ± 40.0
Triglycerides (mg/dl) 164.8 ± 99.0
Creatinine (mg/dl) 1.0 ± 0.9
Albumin (g/dl) 4.6 ± 1.0
25-0H D Vitamin (ng/ml) 26.8 ± 9.3
Homocysteine (μmol/l) 15.1 ± 6.3
B12 Vitamin (ng/ml) 378.5 ± 151.8
Folate (ng/ml) 9.8 ± 13.7
  1. MSM men sex with men; IDU injection drug users; NRTI nucleoside reverse transcriptase inhibitor; NNRTI non-nucleoside reverse transcriptase inhibitor; IP Protease Inhibitors; INSTIs Integrase strand transfer inhibitors